We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The PPMA, a Pakistani drugmakers' association, has claimed that a five-year,
100,000-sample study indicates that counterfeit drugs amount to just 0.4% of
the country's pharmaceutical output.
The Organisation of Pharmaceutical Producers of India (OPPI) and the Indian
Drug Manufacturers Association (IDMA) have reached a consensus that the recent
amendments in the value added tax (VAT) norms for drugs in Maharashtra state
to collect the tax at the manufacturer's level as a single point tax based on
MRP.
GlaxoSmithKline Pharmaceuticals (GSK) has started its buyback programme on Thursday
by acquiring around a 1.5 percent stake (13,23,951 shares) from the open market
for a consideration of Rs 106 crore.
Oxford BioMedica, the leading gene therapy company, Viragen, Inc. and the Roslin
Institute (Scotland) announced a breakthrough in their collaborative project
to develop Avian Transgenic Biomanufacturing.
Cancer drug developer Antisoma announces that it has signed an agreement with
German specialist manufacturer Heraeus to provide supplies of AS1410 for clinical
trials.
Exelixis, Inc. announced that
it has signed a collaboration agreement with Genentech for the discovery and
development of therapeutics to target cancer, inflammatory diseases, and tissue
growth and repair.
Controversy-prone South African Health Minister Manto Tshabalala-Msimang has
stoked further debate over the government's recently introduced drug pricing
reform.